Open Access

Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOtor deficits (MAESTOSO) study protocol

Christopher P L H Chen, Romulo U Esagunde, Cyrus G Escabillas, John Harold Hiyadan, Joel M Advincula, Christian Oliver C Co, Maria Epifania V Collantes, Annabelle Y Lao, Yeow-Hoay Koh, Deidre Anne De Silva, Carol Huilian Tham, Johnny K Lokin, Narayanaswamy Venketasubramanian
DOI: 10.1136/svn-2024-003750 Published 6 February 2025
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

No eLetters have been published for this article.
Back to top
Email
Print
Alerts
Citation Tools
Cite This
Download PDF

Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOtor deficits (MAESTOSO) study protocol
Christopher P L H Chen, Romulo U Esagunde, Cyrus G Escabillas, John Harold Hiyadan, Joel M Advincula, Christian Oliver C Co, Maria Epifania V Collantes, Annabelle Y Lao, Yeow-Hoay Koh, Deidre Anne De Silva, Carol Huilian Tham, Johnny K Lokin, Narayanaswamy Venketasubramanian
Stroke and Vascular Neurology Feb 2025, svn-2024-003750; DOI: 10.1136/svn-2024-003750
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article